Pharma Stock ‘Mattered More Than the Price of a Life,’ Physician Tells Senate Roundtable

“It is nearly impossible to publish data that go against the national public health narrative. If doctors cannot publish the data, they cannot find solutions to fix the problems.” — Dr. Sabine Hazan


https://childrenshealthdefense.org/defender/drugmakers-prioritize-profits-covid-senate-roundtable/

Join https://t.me/RogerHodkinson
🚨 Pharma Stock ‘Mattered More Than the Price of a Life,’ Physician Tells Senate Roundtable “It is nearly impossible to publish data that go against the national public health narrative. If doctors cannot publish the data, they cannot find solutions to fix the problems.” — Dr. Sabine Hazan ⬇️ https://childrenshealthdefense.org/defender/drugmakers-prioritize-profits-covid-senate-roundtable/ Join 👉 https://t.me/RogerHodkinson
CHILDRENSHEALTHDEFENSE.ORG
Pharma Stock ‘Mattered More Than the Price of a Life,’ Physician Tells Senate Roundtable
Experts who testified at Sen. Ron Johnson’s COVID-19 roundtable described how regulators stifled data, silenced dissenting views and made it possible for drugmakers to prioritize profits over patients under a system where “the price of the stock mattered more than the price of a life.”
Angry
1
0 Comments 1 Shares 878 Views